Cognition Therapeutics, Inc. (CGTX) vs Equillium, Inc. (EQ)
A side-by-side comparison of Cognition Therapeutics, Inc. and Equillium, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGTX
Cognition Therapeutics, Inc.
$0.94HealthcareDelayed quote: Oct 6, 2026, 3:40 PM EDT
EQ
Equillium, Inc.
$1.44HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — CGTX vs EQ
growth of $100 · dividends reinvested · last 5yCGTX -92.7% (-40.7%/yr)EQ -78.8% (-26.7%/yr)EQ compounded faster over this window
CGTX EQ
CGTX vs EQ: by the numbers
- •EQ is the larger company ($91M vs $84M market cap).
Metrics side by side
Valuation
| Metric | CGTX | EQ |
|---|---|---|
| P/B ratio | 2.55 | 1.63 |
Profitability
| Metric | CGTX | EQ |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -50.80% | -32.15% |
| ROIC | -109.43% | -34.10% |
Growth (annualized)
| Metric | CGTX | EQ |
|---|---|---|
| Total return CAGR (5Y) | N/A | -26.99% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.